A Randomised, Double-Blinded, Placebo-Controlled, Multicenter, Phase II Study to Evaluate Senaparib Maintenance in mCRPC Patients with Homologous Recombination Repair Gene Alterations after Docetaxel Treatment

  • Pook, David (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date29/09/21 → 31/12/24

Keywords

  • mCRPC
  • Metastatic Castration-Resistant Prostate Cancer
  • Prostate Cancer
  • Urology
  • Clinical trial